(Q38179980)

English

Rituximab for treating CD20+ prostate cancer with generalized lymphadenopathy: a case report and review of the literature

scientific article published on 18 January 2014

Statements

Rituximab for treating CD20+ prostate cancer with generalized lymphadenopathy: a case report and review of the literature (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit